- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
EBO
ASX
Week ended 07 Aug 2026
Weekly Investor Report
EBOS Group Limited · Healthcare · Medical Distribution
Latest close
18.36 AUD
-1.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -1.2% below the Trend Line and sits at 12.7% of its 52-week range. The latest completed week returned -1.3%, after a 2.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100.
Setup score
39
out of 100
Latest Close
18.36 AUD
7 Aug 2026
1W Return
-1.3%
latest completed week
4W Return
2.1%
short-term follow-through
12W Return
7.4%
quarterly tape
Trend Breadth
3.8%
2 of 52 weeks active
Volume Ratio
2.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.3%
Latest completed week; four-week move 2.1%.
Indicator stack
2/80
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
15 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -1.2% below the Trend Line and sits at 12.7% of its 52-week range. The latest completed week returned -1.3%, after a 2.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1412-week average 0.04
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.1% over four weeks, 7.4% over 12 weeks, and -49.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year2
Trend breadth3.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.41Latest activity-pressure read.
Pressure change63.7%Four-week change in activity pressure.
Leadership-19.12Latest relative-leadership reading.
RS change11.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 30 Jun 2025
Field coverage 85%
Model confidence 43%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength54/100Blend of value, momentum, and quality. Underlying universe rank 47; rank 1 is best.
Value95/100Relative valuation strength. Underlying universe rank 6; rank 1 is best.
Quality14/100Profitability and accounting quality. Underlying universe rank 87; rank 1 is best.
Momentum4/100Medium-term price momentum. Underlying universe rank 97; rank 1 is best.
Growth3/100Revenue and earnings growth. Underlying universe rank 98; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework75/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 16.3x Price divided by trailing earnings.
- Price / sales
- 0.3x Market value relative to trailing revenue.
- EV / EBITDA
- 9.2x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 7.4% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 13.3% Gross profit retained from each unit of revenue.
- Operating margin
- 3.4% Operating profit retained from revenue.
- Free-cash-flow margin
- 3.0% Free cash flow generated from revenue.
- Return on invested capital
- 7.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -8.3% Latest one-year revenue growth.
- EPS growth
- -25.8% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 37.5% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 5.0% Cash dividends relative to market value.
- Buyback yield
- -7.1% Net share repurchases relative to market value.
- Shareholder yield
- -2.2% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 15 relevant articles.
3 positive · 9 neutral · 3 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-50.1%Distance below the 52-week high.
13-week volatility3.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+5.6%Week of 17 Jul.
Worst week-5.2%Week of 13 Feb.
Latest week-1.3%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains6
Flat weeks0
Modest losses12
Sharp losses4
Recent vol3.3%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split17/35Count of positive and negative weeks in the 52-week window.
Average skew2.4% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Healthcare
4-week rank41 / 100
Group average-0.9%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD58.0%positive activity pressure
RS26.0%positive relative leadership
Four-week leaders
IndustryAU Medical Distribution
4-week rank4 / 5
Group average2.8%
Trend breadth20.0%
Trend20.0%active weekly trend signals
MD80.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape34/100
Trend, activity pressure, participation, and risk combine to a 34/100 tape read.
Indicator analysis27/100Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.
Activity pressure 0.14; No reversal markers Factors41/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 79 SVQF75/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 64.0 of 257 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 15 relevant articles.
EBOS Group (ASX:EBO) Dividend Profile: Examining Its 4.97% Yield and Healthcare Services Exposure Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 18.36 AUD | -1.3% | 18.58 AUD | 28.32 AUD | 1.41 | -19.12 | 833.0K | Off |
| 31 Jul 2026 | 18.61 AUD | 2.0% | 18.73 AUD | 28.39 AUD | 1.36 | -16.78 | 384.6K | Off |
| 24 Jul 2026 | 18.25 AUD | -3.9% | 18.88 AUD | 28.47 AUD | 1.24 | -17.74 | 325.1K | Off |
| 17 Jul 2026 | 18.99 AUD | 5.6% | 19.06 AUD | 28.56 AUD | 1.05 | -15.99 | 481.7K | Off |
| 10 Jul 2026 | 17.98 AUD | 2.9% | 19.21 AUD | 28.64 AUD | 0.86 | -21.63 | 462.4K | Off |
| 3 Jul 2026 | 17.47 AUD | 4.2% | 19.39 AUD | 28.73 AUD | 0.72 | -25.31 | 86.8K | Off |
| 26 Jun 2026 | 16.76 AUD | -0.9% | 19.60 AUD | 28.82 AUD | 0.53 | -28.79 | 94.0K | Off |
| 19 Jun 2026 | 16.91 AUD | -3.9% | 19.85 AUD | 28.91 AUD | 0.32 | -29.71 | 453.3K | Off |
| 12 Jun 2026 | 17.59 AUD | 5.2% | 20.11 AUD | 29.00 AUD | 0.13 | -27.70 | 128.9K | Off |
| 5 Jun 2026 | 16.72 AUD | 2.6% | 20.34 AUD | 29.08 AUD | -0.08 | -30.73 | 390.6K | Off |
| 29 May 2026 | 16.29 AUD | -1.6% | 20.59 AUD | 29.16 AUD | -0.11 | -34.23 | 83.7K | Off |
| 22 May 2026 | 16.56 AUD | -3.1% | 20.87 AUD | 29.28 AUD | -0.09 | -33.49 | 478.8K | Off |
| 15 May 2026 | 17.09 AUD | -2.3% | 21.14 AUD | 29.40 AUD | -0.15 | -32.15 | 409.5K | Off |
| 8 May 2026 | 17.49 AUD | 0.4% | 21.39 AUD | 29.53 AUD | -0.21 | -32.45 | 680.1K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.